Annovis Bio earnings were -$24.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ANVS earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$5.9M, down 53.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ANVS reported annual earnings of -$24.6M, with -56.2% growth. The next ANVS earnings date is May 8, 2025.
On ANVS's earnings call on Invalid Date, Annovis Bio (NYSE: ANVS) reported Q4 2024 earnings per share (EPS) of -$0.38, up 83.69% year over year. Total ANVS earnings for the quarter were -$5.86 million. In the same quarter last year, Annovis Bio's earnings per share (EPS) was -$2.33.
The next ANVS earnings date is Invalid Date. Add ANVS to your watchlist to be reminded of Annovis Bio's next earnings date.
Is Annovis Bio profitable or losing money?
As of the last Annovis Bio earnings report, Annovis Bio is currently losing money. Annovis Bio's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$24.59 million, a 56.25% decrease year over year.
What was ANVS's earnings growth in the past year?
As of Annovis Bio's earnings date in Invalid Date, Annovis Bio's earnings has grown year over year. ANVS earnings in the past year totalled -$24.59 million.
What are Annovis Bio's earnings expectations?
The current EPS estimate for Annovis Bio's earnings report in Invalid Date is -$0.80.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.